Antimicrobial optimisation.

• Date : 2016-03-16
• 3    
  0

Keynote 1:Patient partnership in healthcare, a necessary transition?

• Date : 2016-03-16
• 3    
  0

A systematic approach to pharmaceutical care part 2

• Date : 2016-03-16
• 3    
  0

Keynote 2: Star Trek's tricorder: science fiction or future science?

• Date : 2016-03-16
• 2    
  0

Pharmaceutical care in partnership with patient

• Date : 2016-03-16
• 2    
  0

The role of pharmacists in multidisciplinary teams part 2

• Date : 2016-03-16
• 2    
  0

Challenges Challenges in Antithrombotic Care

• Date : 2016-03-16
• 2    
  0

How improving the quality of medication management helps to reduce medication errors

• Date : 2016-03-16
• 2    
  0

Hepatitis C antiviral treatments revisited

• Date : 2016-03-16
• 2    
  0

HIV antiviral treatment revisited

• Date : 2016-03-16
• 2    
  0

Standardization & Centralization.

• Date : 2016-03-16
• 2    
  0

Evidence confirms clinical profile of dabigatran

• Date : 2016-03-16
• 2    
  0

Patient generated information

• Date : 2016-03-16
• 2    
  0

Empowering patients through technology.

• Date : 2016-03-16
• 2    
  0

Intro/ what is a biosimilar

• Date : 2016-03-16
• 2    
  0

Antifungal stewardship, a specialist's view

• Date : 2016-03-16
• 2    
  0

E-Health.

• Date : 2016-03-16
• 2    
  0

Keynote 3: Exploring the future of pharmacotherapy. Bert Leufkens

• Date : 2016-03-16
• 2    
  0

Pharmacy Technicians Support the Administration of I.V's.

• Date : 2016-03-16
• 2    
  0

Clinical pathways part 1

• Date : 2016-03-16
• 2    
  0

Pharmacy information for safer transition of care.

• Date : 2016-03-16
• 2    
  0

Pharmacy information for safer transition of care part2

• Date : 2016-03-16
• 2    
  0

First specific reversal agent for a NOAC now available.

• Date : 2016-03-16
• 2    
  0

Optimal chemotherapy delivery.

• Date : 2016-03-16
• 1    
  0

Patient and health professional

• Date : 2016-03-16
• 1    
  0

The_art_of_writing_an_abstract

• Date : 2016-03-16
• 1    
  0

How can we control the risks?

• Date : 2016-03-16
• 1    
  0

Developing and implementing clinical pathways

• Date : 2016-03-16
• 1    
  0

Hospital Pharmacists taking the lead in Orphan Drugs.

• Date : 2016-03-16
• 1    
  0

Implementing new technology part 1

• Date : 2016-03-16
• 1    
  0

Is there a need for them and how do we get them?

• Date : 2016-03-16
• 1    
  0

Implementing new technology part 2

• Date : 2016-03-16
• 1    
  0

Implementing new technology part 3

• Date : 2016-03-16
• 1    
  0

Antifungal stewardship: Where are we today?

• Date : 2016-03-16
• 1    
  0

How to address the misconceptions about biosimilars.

• Date : 2016-03-16
• 1    
  0

The Role of Pharmacists in Multidisciplinary Teams part 1

• Date : 2016-03-16
• 1    
  0

Infusion medication safety at the bedside: experience in pediatric care.

• Date : 2016-03-16
• 1    
  0

NOAC dosing regimens to optimize patient protection.

• Date : 2016-03-16
• 1    
  0

Reducing the impact on healthcare resources

• Date : 2016-03-16
• 1    
  0

Novel ways of dispensing drugs

• Date : 2016-03-16
• 1    
  0

A systematic approach to pharmaceutical care part 1

• Date : 2016-03-16
• 1    
  0

What happens when children start a new medicine?

• Date : 2016-03-16
• 1    
  0

What happens to you, matters to us.

• Date : 2016-03-16
• 1    
  0

New and Emerging Roles for Pharmacy Staff.

• Date : 2016-03-16
• 1    
  0

New tools to detect medication non-adherence

• Date : 2016-03-16
• 1    
  0

E-learning: where to use and how to implement

• Date : 2016-03-16
• 1    
  0

E-learning: application and implementation

• Date : 2016-03-16
• 1    
  0

Are clinical decision support systems beneficial for everyone?

• Date : 2016-03-16
• 1    
  0

Continuum of care for oncology pharmacist

• Date : 2016-03-16
• 1    
  0

New antibiotics & alternatives to antibiotic therapy

• Date : 2016-03-16
• 1    
  0

Advanced-therapy medicinal products

• Date : 2016-03-16
• 1    
  0

The rules of engagement in Europe.

• Date : 2016-03-16
• 1    
  0

Advanced-therapy medicinal products part 2

• Date : 2016-03-16
• 1    
  0

Introduction to TDM

• Date : 2016-03-16
• 1    
  0

Introduction to Population Pharmacokinetic modeling

• Date : 2016-03-16
• 1    
  0

Reviving old antibiotics

• Date : 2016-03-16
• 1    
  0

TDM of Anti-Cancer Drugs

• Date : 2016-03-16
• 0    
  0

Introducing Biosimilars into the Hospital Formulary.

• Date : 2016-03-16
• 0    
  0

Interchangeability of biosimilars - a financial, ethical, or scientific issue?

• Date : 2016-03-16
• 0    
  0

The pharmacist's role in antimicrobial stewardship in Spain.

• Date : 2016-03-16
• 0    
  0

Role of the pharmacist in antimicrobial stewardship programmes

• Date : 2016-03-16
• 0    
  0

Therapeutic Drug Monitoring of Antibacterials

• Date : 2016-03-16
• 0    
  0

Clinical pathways part 2

• Date : 2016-03-16
• 0    
  0

Biosimilars, the physician's learning curve.

• Date : 2016-03-16
• 0    
  0

Electronic prescribing. Jacqueline Surugue

• Date : 2016-03-16
• 0    
  0

Is our present system economically sustainable?

• Date : 2016-03-16
• 0    
  0

Cancer Therapy: Overview and look to the future

• Date : 2016-03-16
• 0    
  0

38ᵉ Congrès du Collège Européen de Neuropsychopharmacologie - ECNP 2025

• Date : 2025-10-11
• 652    
  0

Congrès Psych 2025

• Date : 2025-09-17
• 1205    
  0

Réunion Annuelle de l'American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2025

• Date : 2025-05-28
• 623    
  0

3rd International Conference on Pediatrics and Healthcare

• Date : 2025-05-15
• 2023    
  0

CPHI 2024

• Date : 2024-10-08
• 3730    
  0